Top Pharmaceuticals companies in Switzerland by EBIT Margin
Switzerland
# |
Name |
EBIT Margin |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
73.62%
|
Dec. 31, 2023 | USD 14.50 | 8.00% |
|
Switzerland |
|
| 2 |
28.63%
|
March 31, 2024 | USD 229.49 | 0.50% |
|
Switzerland |
|
| 3 |
24.73%
|
Dec. 31, 2023 | USD 310.22 | 0.71% |
|
Switzerland |
|
| 4 |
22.41%
|
Dec. 31, 2023 | USD 61.01 | 0.32% |
|
Switzerland |
|
| 5 |
21.38%
|
Dec. 31, 2023 | USD 98.71 | -0.26% |
|
Switzerland |
|
| 6 |
15.85%
|
March 31, 2024 | USD 355.46 | -1.48% |
|
Switzerland |
|
| 7 |
15.45%
|
Dec. 31, 2023 | USD 129.81 | 2.09% |
|
Switzerland |
|
| 8 |
15.04%
|
Dec. 31, 2023 | USD 85.22 | -0.53% |
|
Switzerland |
|
| 9 |
14.98%
|
Dec. 31, 2023 | USD 119.40 | 0.87% |
|
Switzerland |
|
| 10 |
13.71%
|
Dec. 31, 2023 | USD 44.53 | -0.85% |
|
Switzerland |
|
| 11 |
13.56%
|
Dec. 31, 2023 | USD 588.68 | -0.80% |
|
Switzerland |
|
| 12 |
12.57%
|
Dec. 31, 2023 | USD 1.04 K | -2.38% |
|
Switzerland |
|
| 13 |
12.54%
|
Dec. 31, 2023 | USD 244.50 | 0.95% |
|
Switzerland |
|
| 14 |
12.06%
|
Dec. 31, 2023 | USD 165.41 | 0.50% |
|
Switzerland |
|
| 15 |
11.80%
|
Dec. 31, 2023 | USD 81.72 | -0.97% |
|
Switzerland |
|
| 16 |
10.80%
|
Dec. 31, 2023 | USD 82.92 | 0.05% |
|
Switzerland |
|
| 17 |
9.29%
|
Dec. 31, 2023 | USD 140.65 | 0.97% |
|
Switzerland |
|
| 18 |
6.99%
|
Dec. 31, 2023 | USD 56.52 | -0.28% |
|
Switzerland |
|
| 19 |
6.55%
|
Dec. 31, 2023 | USD 1.16 K | 0.97% |
|
Switzerland |
|
| 20 |
5.44%
|
Dec. 31, 2023 | USD 84.29 | 1.29% |
|
Switzerland |
|
| 21 |
5.40%
|
Dec. 31, 2023 | USD 73.39 | 4.71% |
|
Switzerland |
|
| 22 |
3.33%
|
Dec. 31, 2023 | USD 42.16 | 0.08% |
|
Switzerland |
|
| 23 |
3.29%
|
Dec. 31, 2023 | USD 11.09 | -3.14% |
|
Switzerland |
|
| 24 |
2.79%
|
Dec. 31, 2023 | USD 73.83 | -0.24% |
|
Switzerland |
|
| 25 |
-4.56%
|
Dec. 31, 2023 | USD 97.52 | 0.29% |
|
Switzerland |
|
| 26 |
-10.11%
|
Dec. 31, 2023 | USD 19.40 | 2.88% |
|
Switzerland |
|
| 27 |
-16.42%
|
Dec. 31, 2023 | USD 27.99 | -3.47% |
|
Switzerland |
|
| 28 |
-39.21%
|
Dec. 31, 2023 | USD 24.15 | -4.07% |
|
Switzerland |
|
| 29 |
-59.95%
|
Dec. 31, 2023 | USD 38.36 | -1.26% |
|
Switzerland |
|
| 30 |
-215.69%
|
Dec. 31, 2023 | USD 1.71 | -0.58% |
|
Switzerland |
|
| 31 |
-365.16%
|
Dec. 31, 2023 | USD 2.61 | NA |
|
Switzerland |
|
| 32 |
-653.13%
|
Dec. 31, 2023 | USD 7.39 | -3.40% |
|
Switzerland |
|
| 33 |
-880.01%
|
Dec. 31, 2023 | USD 5.48 | 3.60% |
|
Switzerland |
|
| 34 |
-5,192.64%
|
Dec. 31, 2023 | USD 22.44 | 0.27% |
|
Switzerland |
Frequently Asked Questions
-
Which Pharmaceuticals company in Switzerland has the highest EBIT Margin ?
The Pharmaceuticals company in Switzerland with the highest EBIT Margin is Santhera Pharmaceuticals Holding AG (Swiss Stock Exchange: SANN.SW) at 73.62%.
-
Which Pharmaceuticals company in Switzerland has the lowest EBIT Margin ?
The Pharmaceuticals company in Switzerland with the lowest EBIT Margin is Oculis Holding AG (NasdaqGM: OCS) at -5,192.64%.
-
What are the top 10 Pharmaceuticals companies in Switzerland by EBIT Margin ?
The top 10 Pharmaceuticals companies in Switzerland by EBIT Margin are Santhera Pharmaceuticals Holding AG, Dottikon Es Holding AG, Roche Holding AG, Bachem Holding AG, Novartis AG, Ypsomed Holding AG, Straumann Holding AG, CPH Chemie + Papier Holding AG, Medacta Group SA and Basilea Pharmaceutica AG.
-
What are the bottom 10 Pharmaceuticals companies in Switzerland by EBIT Margin ?
The bottom 10 Pharmaceuticals companies in Switzerland by EBIT Margin are Oculis Holding AG, Molecular Partners AG, Addex Therapeutics Ltd, AC Immune SA, ADC Therapeutics SA, CRISPR Therapeutics AG, Kuros Biosciences AG, PolyPeptide Group AG, DocMorris AG and DSM-Firmenich AG.